HISWAI shows you what’s connected to topics that interest you, and where to find more. HISWAI members can curate information with dashboards to gain insights, proper context and stay up to date on the latest relevant information. Sharing these discoveries with others is easy too!
Date: 2022-09-30 19:02:20
Tags for this article:
Aurora Cannabis Inc. (NASDAQ:ACB) price on Thursday, September 29, fall -3.85% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $1.25.
A look at the stock’s price movement, the close in the last trading session was $1.30, moving within a range at $1.22 and $1.29. The beta value (5-Year monthly) was 3.04. Turning to its 52-week performance, $8.69 and $1.12 were the 52-week high and 52-week low respectively. Overall, ACB moved -17.76% over the past month.
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Aurora Cannabis Inc.’s market cap currently stands at around $392.19 million, with investors looking forward to this quarter’s earnings report slated for Nov 07, 2022 – Nov 11, 2022. Analysts project the company’s earnings per share (EPS) to be -$0.16, which has seen fiscal year 2022 EPS growth forecast to increase to -$4.02 and about -$0.35 for fiscal year 2023. Per the data, EPS growth is expected to be -24.80% for 2022 and 91.30% for the next financial year.
Analysts have a consensus estimate of $39.79 million for the company’s revenue for the quarter, with a low and high estimate of $38.14 million and $41.4 million respectively. The average forecast suggests down to a -7.60% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue for 2022 to grow to $174.42 million, representing a -9.50% decline on that reported in the last financial year.
Revisions could be used as tool to get short term price movement insight, and for the company that in the past seven days was no upward and no downward review(s). Turning to the stock’s technical picture we see that short term indicators suggest on average that ACB is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
12 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 10 analyst(s) rate the stock as a Hold, 1 recommend ACB as a Buy and 1 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Hold which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
ACB’s current price about -11.82% and -16.61% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 41.44, while 7-day volatility ratio is 7.83% and 7.18% in the 30-day chart. Further, Aurora Cannabis Inc. (ACB) has a beta value of 2.99, and an average true range (ATR) of 0.11. Analysts have given the company’s stock an average 52-week price target of $1.70, forecast between a low of $1.09 and high of $3.00. Looking at the price targets, the low is 12.8% off current price level while to achieve the yearly target high, price needs to move -140.0%. Nonetheless, investors will most likely welcome a -19.2% jump to $1.49 which is the analysts’ median price.
In the market, a comparison of Aurora Cannabis Inc. (ACB) and its peers suggest the former has performed considerably weaker. Data shows ACB’s intraday price has changed -3.85% in last session and -81.45% over the past year. Elsewhere, the overall performance for the S&P 500 and Dow Jones Industrial shows that the indexes are down -2.11% and -1.54% respectively in the last trading.
If we refocus on Aurora Cannabis Inc. (NASDAQ:ACB), historical trading data shows that trading volumes averaged 8.88 million over the past 10 days and 9.78 million over the past 3 months. The company’s latest data on shares outstanding shows there are 248.97 million shares.
The 0.10% of Aurora Cannabis Inc.’s shares are in the hands of company insiders while institutional holders own 32.02% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 26.33 million on Jul 14, 2022, giving us a short ratio of 2.91. The data shows that as of Jul 14, 2022 short interest in Aurora Cannabis Inc. (ACB) stood at 8.84% of shares outstanding, with shares short rising to 25.63 million registered in Jun 14, 2022. Current price change has pushed the stock -76.89% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ACB stock continues to rise going into the next quarter.